Methodological approach for assessing the cost-effectiveness of treatments using longitudinal observational data: The SOHO study

International Journal of Technology Assessment in Health Care

Volumn 22, Issue 4, 2006, Pages 460-468

  Windmeijer, Frank ^a   Kontodimas, Stathis ^b   Knapp, Martin ^c   Brown, Jacqueline ^b   Haro, Josep Maria ^d,e  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ELI LILLY AND COMPANY   (United States)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^d Fundacio Hospital Sant Joan de Déu   (Spain)

^e Fundacion Sant Joan de Deu   (Spain)

Author keywords

Cost effectiveness; Epoch analysis; Longitudinal data; Observational studies

Indexed keywords

COST EFFECTIVENESS; DATA REDUCTION; FUNCTION EVALUATION; MEDICAL APPLICATIONS; PARAMETER ESTIMATION; REGRESSION ANALYSIS;

BOOTSTRAP SAMPLES; EPOCH ANALYSIS; LONGITUDINAL DATA; OBSERVATIONAL STUDIES;

PATIENT TREATMENT;

NEUROLEPTIC AGENT; OLANZAPINE;

ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; DRUG SUBSTITUTION; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE COST; MENTAL PATIENT; METHODOLOGY; MODEL; MULTIVARIATE ANALYSIS OF COVARIANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; OUTPATIENT; QUALITY ADJUSTED LIFE YEAR; SCHIZOPHRENIA; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

ANTIPSYCHOTIC AGENTS; COSTS AND COST ANALYSIS; CROSS-OVER STUDIES; HEALTH CARE COSTS; HUMANS; LONGITUDINAL STUDIES; QUALITY-ADJUSTED LIFE YEARS; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TIME FACTORS; TREATMENT OUTCOME; UNCERTAINTY;

EID: 33750315755     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462306051385     Document Type: Article

References (19)

1. Briggs AH. Handling uncertainty in economic evaluation and presenting the results. In: Drummond M, McGuire A, eds. Economic evaluation in health care: Merging theory with practice. New York, NY: Oxford University Press; 2001:172-214.
2. Brooks R. EuroQol: The current state of play. Health Policy. 1996;37:53-72.
3. Covell NH, Jackson CT, Evans AC, Essock SM. Antipsychotic prescribing practices in Connecticut's public mental health system: Rates of changing medications and prescribing styles. Schizophr Bull. 2002;28:17-29.
4. Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003; 7:1-173.
5. Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decision? A binary choice analysis. Health Econ. 2004:13;437-452.
6. Haro JM, Edgell ET, Jones PB, et al. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: Rationale, methods and recruitment. Acta Psychiatr Scand. 2003;107:222-232.
7. Haro JM, Edgell ET, Novick D, et al. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatr Scand. 2005;111:220-231.
8. Lehman AF, Lieberman JA, Dixon LB, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(Suppl):1-56.
9. McKee M, Britton A, Black N, et al. Methods in health services research: Interpreting the evidence: Choosing between randomised and non-randomised studies. BMJ. 1999;319:312-315.
10. Manning WG, Mullahy J. Estimating log models: To transform or not to transform? J Health Econ. 2001;20:461-494.
11. Monthly Index of Medical Specialities (MIMMS). London: Haymarket Medical Publications; February 2005.
12. Netten A, Curtis L. Unit costs of health and social care 2002. Canterbury, Kent: University of Kent Personal Social Services Research Unit; 2002.
13. Netten A, Curtis L. Unit costs of health and social care 2003. Canterbury, Kent: University of Kent Personal Social Services Research Unit; 2003.
14. Netten A, Curtis L. Unit costs of health and social care 2004. Canterbury, Kent: University of Kent Personal Social Services Research Unit; 2004.
15. Park R. Estimation with heteroscedastic error terms. Econometrica. 1966;34:888.
16. Raikou M, Briggs A, Gray A, McGuire A. Centre-Specific or average unit costs in multi-centre studies? Some theory and simulation. Health Econ. 2000;9:191-198.
17. Rosenbaum PR. Observational studies. London: Springer; 2002.
18. Santos Silva JMC, Tenreyro S. The log of gravity. CEPR Discussion Paper Series, No. 5311; 2005.
19. Willke RJ, Glick HA, Polsky D, Schulman K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ. 1998;7:481-493.